Today’s guest post comes from Deepak Thomas, Founder and CEO of PHIL.
Deepak explores how demographic shifts and digital expectations are reshaping patient engagement. He argues that to stay competitive, pharmaceutical manufacturers must adopt integrated direct-to-patient (DTP) platforms that streamline access, support insurance coverage, and deliver sustainable commercial impact.
Click here to learn more about PHIL Direct, PHIL’s integrated DTP solution.
Read on for Deepak’s insights.
Read more »
Source: Post feed
